Evidence map›Paper›PMID 29491315›Full record

ArticleInternal medicine (Tokyo, Japan)2018

The Clinical Findings Useful for Driving Safety Advice for Parkinson's Disease Patients.

Rina Ando, Hirotaka Iwaki, Tomoaki Tsujii, Masahiro Nagai, Noriko Nishikawa, Hayato Yabe, Ikuko Aiba, Kazuko Hasegawa, Yoshio Tsuboi, Masashi Aoki and 3 more

Open access · diamondAbstract readComparative Study
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Rina AndoDepartment of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan.
Hirotaka IwakiDepartment of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan.
Tomoaki TsujiiDepartment of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan.
Masahiro NagaiDepartment of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan.
Noriko NishikawaDepartment of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan.
Hayato YabeDepartment of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan.
Ikuko AibaDepartment of Neurology, Higashi Nagoya Hospital, Japan.
Kazuko HasegawaDepartment of Neurology, Sagamihara National Hospital, Japan.
Yoshio TsuboiDepartment of Neurology, Fukuoka University, Japan.
Masashi AokiDepartment of Neurology, Tohoku University School of Medicine, Japan.
Kenji NakashimaDepartment of Neurology, Tottori University Faculty of Medicine, Japan.
Masahiro NomotoDepartment of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan.
Parkinson's Disease Safe Driving Study Group of Japan
Ehime University · JPFukuoka University · JPHigashi Osaka City General Hospital · JPNational Sagamihara Hospital · JPTohoku University · JPTottori University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective We conducted a study to obtain information that could be used to provide Parkinson's disease (PD) patients with appropriate advice on safe driving. Methods Consecutive PD patients who visited our office were studied. Among these patients, those who had experienced driving after being diagnosed with PD were interviewed by neurologists and a trained nurse to investigate their previous car accidents, motor function, cognitive function, sleepiness, levodopa equivalent dose (LED), and emotional dysregulation. The rates of major car accidents before and after the onset of PD were compared. Results Fifteen patients had experienced a major car accident resulting in human injury or serious property damage since the onset of PD. When the rates of major car accidents before and after the onset of PD were compared, the ratio was 4.3 [95% confidence interval (CI) 1.9-9.7]. The incidence of accidents after the onset of PD was correlated with age, disease duration, LED, the cognitive function Mini-Mental Scale Examination (MMSE), Japanese translation of the Montreal Cognitive Assessment (MoCA-J), but not the motor symptom score [Unified Pankinson's disease rating scale (UPDRS) part III at the time of the study]. The Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP) score was also higher in patients with major car accidents. Conclusion The severity of symptoms (Hoehn-Yahr classification), cognitive function, and disease duration were expected to be risk factors for car accidents. However, the motor symptom score (UPDRS part III) was not associated with the incidence of major car accidents. In addition to a low cognitive function and the severity of symptoms, the QUIP score might be an independent factor that can be referenced when advising PD patients to refrain from driving.

Indexed as

Automobile DrivingAccidents, TrafficAdultAgedAged, 80 and overAntiparkinson AgentsCognitionFemaleHumansLevodopaMaleMiddle AgedParkinson DiseaseRisk FactorsSurveys and QuestionnairesAntiparkinson AgentsLevodopaadvice to refrain from drivingcar accidentdrivingParkinson's diseasesafety

Identifiers

PMID29491315
PMCPMC6096020
OpenAlexW2792776271

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.